期刊文献+

肿瘤血管阻断剂vadimezan的合成 被引量:3

Synthesis of Tumor Vascular Disrupting Agent Vadimezan
原文传递
导出
摘要 2,3-二甲基苯胺与水合氯醛、盐酸羟胺经缩合反应生成2,3-二甲基异亚硝基乙酰苯胺,经脱水环合、开环及重氮化水解得2-羟基-3,4-二甲基苯甲酸,再与邻氯苯乙酸醚化和分子内付-克酰化反应制得肿瘤血管阻断剂vadimezan,总收率为40%。 Vadimezan,a vascular disrupting agent,was synthesized from 2,3-dimethylaniline by condensation with chloral hydrate and hydroxylamine hydrochloride to give 2,3-dimethyl-a-isonitrosoacetanilide,which was subjected to cyclization and ring opening to give 2-amino-3,4-dimethylbenzoic acid,followed by diazotization and hydrolysis,etherification with 2-chlorophenylacetic acid,and then Friedel-Crafts reaction with an overall yield of about 40%.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2011年第4期248-250,共3页 Chinese Journal of Pharmaceuticals
关键词 vadimezan 肿瘤血管阻断剂 合成 vadimezan vascular disrupting agent synthesis
  • 相关文献

参考文献9

  • 1任萱,孙启明,林莉萍,丁健.肿瘤血管靶向药物的研究进展[J].生命科学,2007,19(4):427-432. 被引量:9
  • 2Denny WA,Baguley BC,Atwell GJ,et al.Compouds havingantitumour and antibacterial properties. EP,278176 . 1988
  • 3Rehman F,Rustin G.ASA404:update on drug development. Expert Opinion on Investigational Drugs . 2008
  • 4Lippert JW.Vascular disrupting agents. Bioorganic and Medicinal Chemistry Letters . 2007
  • 5Atwell GJ,Yang S,DennyWA,et al.An improved synthesisof 5,6-dimethylxanthenone-4-acetic acid(DMXAA). EurJ Med Chem . 2002
  • 6Denny WA,Yang S.Synthesis of 5,6-dimethyl-9-oxo-9H-xanthene-4-yl acetic acids. WO,8048117 . 2008
  • 7GORDON W R,,GRAHAM J A,LI Zhuang,et al.Po-tential antitumor agents.61.structure-activity relation-ships for in vivo colon38activity among disubstituted9-oxo-9H-xanthene-4-acetic acids. Journal of Medicinal Chemistry . 1991
  • 8Ching L M,Cao Z,Kieda C,et al.Induction of endothelial cell apoptosis by the antivascular agent5,6-Dimethylxanthe-none-4-acetic acid. British Journal of Cancer . 2002
  • 9Tozer G M,Kanthou C,Baguley B C.Disrupting tumour blood vessels. Nature Reviews Cancer . 2005

二级参考文献39

  • 1Ausprunk D H,Folkman J.Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis.Microvasc Res,1977,14(1):53-65.
  • 2Denekamp J.Review article:angiogenesis,neovascular proliferation and vascular pathophysiology as targets for cancer therapy.Br J Radiol,1993,66(783):181-196.
  • 3Folkman J.Seminars in medicine of the Beth Israel Hospital,Boston.Clinical applications of research on angiogenesis.N Engl J Med,1995,333(26):1757-1763.
  • 4Kanthou C,Greco O,Stratford A,et al.The tubulin-binding agent combretastatin A-4-phosphate arrests endothelial cells in mitosis and induces mitotic cell death.Am J Pathol,2004,165(4):1401-1411.
  • 5Burrows F J,Watanabe Y,Thorpe P E.A murine model for antibody-directed targeting of vascular endothelial cells in solid.Cancer Res,1992,52(21):5954-5962.
  • 6Siemann D W,Chaplin D J,Horsman M R.Vascular-targeting therapies for treatment of malignant disease.Cancer,2004,100(12):2491-2499.
  • 7Denekamp J.Endothelial cell proliferation as a novel approach to targeting tumour therapy.Br J Cancer,1982,45(1):136-139.
  • 8Hill S A,Lonergan S J,Denekamp J.Vinca alkaloids:antivascular effects in a murine tumour.Eur J Cancer,1993,29(9):1320-1324.
  • 9Thorpe P E.Vascular targeting agents as cancer therapeutics.Clin Cancer Res,2004,10(2):415-427.
  • 10Neri D,Bicknell R.Tumour vascular targeting.Nat Rev Cancer,2005,5(6):436-446.

共引文献8

同被引文献7

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部